University of California San Francisco

Bilal Hameed, MBBS

Bilal Hameed - 144
Bilal
Hameed
MBBS

Professor of Medicine
Hepatology and Liver Transplantation
Department of Medicine

Address

400 Parnassus Avenue, #A744
San Francisco, CA 94143
United States

    Biography

    I am a Professor of Medicine and Ambulatory Director of Hepatology. I was the program director for transplant hepatology fellowship. Beside busy clinically my research interest includes nonalcoholic steatohepatitis, PSC, ALF, HCC and cirrhosis. I am the co-PI for NIH funded Liver Cirrhosis Network (LCN) and site-PI for NIH funded NASH-CRN. I am the PI for many clinical trials in NASH and PSC.

    Videos

    Education

    Institution Degree Dept or School End Date
    University of California, San Francisco Transplant Hepatology fellowship 07/2010
    University of Minnesota Gastroenterology fellowship 07/2009
    University of Minnesota Internal Medicine Residency 07/2006
    Dow M.D. School of Medicine 2000

    Board Certifications

    American Board of Internal Medicine
    American Board of Internal Medicine - Gastroenterology

    Clinical Expertise

    Alcoholic Liver Disease
    Autoimmune Hepatitis
    Benign Liver Tumors
    Cirrhosis
    Fulminant Hepatic Failure
    Hepatitis B
    Hepatitis C
    Hepatocellular Carcinoma (Liver Cancer)
    Living Donor Liver Transplantation
    Liver Transplantation
    Nonalcoholic Fatty Liver Disease
    Primary Biliary Cirrhosis
    Primary Sclerosing Cholangitis

    Program Affiliations

    UCSF Liver Transplantation Program

    Research Interests

    Epidemiology and management of NAFLD
    Sleep apnea in NAFLD
    Modeling outcomes in advanced liver disease and liver transplantation.

    Publications

    MOST RECENT PUBLICATIONS FROM A TOTAL OF 10
    1. Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography (GOLDMINE): A Multi-Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical Outcomes.
      Sharpton S, Díaz LA, Pepin K, Amangurbanova M, Madamba E, Bettencourt R, Singh S, Valasek M, Dalupang M, Tesfai K, Middleton MS, Behling C, Dunn W, Nakajima A, Imajo K, Ogawa Y, Caussy C, Halegoua-DeMarzio D, Mohanty A, Huang DQ, Fuchs M, Hameed B, Stine JG, Balakrishnan M, Gray M, Rodriguez M, DeLeon A, Puskoor R, Vuppalanchi R, Behari J, Hansen L, Miller C, Medici V, Sarkar S, Boursier J, Tincopa M, Ajmera V, Richards L, Sirlin CB, Ehman RL, Loomba R, GOLDMINE consortium| | PubMed
    2. Longitudinal changes in cardiometabolic risk factors are associated with changes in liver stiffness in adults with MASLD.
      Dukewich M, Wilson LA, Dodge JL, Yuan L, Hameed B, Yates KP, Loomba R, Neuschwander-Tetri BA, Mack W, Terrault N, NASH Clinical Research Network| | PubMed
    3. New histopathological terminology for well-differentiated hepatocellular lesions in unusual clinico-pathological scenarios: HCA-like and FNH-like.
      Sempoux C, Alves VA, Arola J, Balabaud C, Bioulac-Sage P, Colombari R, Crawford JM, Dhillon AP, di Tommaso L, Ferrell LD, Gill RM, Guido M, Hameed B, Harada K, Hytiroglou P, Nakanuma Y, Paradis V, Rautou PE, Theise ND, Thung S, Tsui WM, Snover D, Stueck A, Suriawinata A, van Leeuwen DJ, Quaglia A, International Liver Pathology Study Group| | PubMed
    4. AASLD AST Practice Guideline on adult liver transplantation: Diagnosis and post-transplant management of non-graft-related complications.
      Sharma P, Izzy M, Ghabril MS, Serper M, Clark VC, Ison MG, Hameed B, Volk M, Brown RS, Humar A, Martin P| | PubMed
    5. The endothelial growth factor angiopoietin-2 is an accurate prognostic biomarker in patients with acetaminophen-induced acute liver failure.
      Umbaugh DS, Nguyen NT, Curry SC, Rule JA, Lee WM, Ramachandran A, Jaeschke H, Acute Liver Failure Study Group| | PubMed
    6. A novel discovery of elevated risk of neuroendocrine tumors in patients with myotonic dystrophy.
      Hameed B, Ahmadzada M, McNeel TS, DiCapua DB, Gadalla SM| | PubMed
    7. Phase II INTEGRIS-PSC trial of bexotegrast, an αvβ6/αvβ1 integrin inhibitor, in primary sclerosing cholangitis.
      Hirschfield GM, Kowdley KV, Trivedi PJ, Eksteen B, Hameed B, Vincent C, Chen T, Goel A, Reddy KG, Orman E, Joshi D, Lefebvre ÉA, Schaub JR, An MC, Clark A, Barnes CN, Pencek R, Thorburn D, Montano-Loza AJ, Schramm C, Bowlus CL, Trauner M, Levy C| | PubMed
    8. Spectrum of Cancers and Their Prognosis Among Patients With Myotonic Dystrophy.
      Gadalla SM, McNeel TS, Wheeler W, Alsaggaf R, Hameed B, Avantsa S, Ahmadzada M, Pfeiffer RM| | PubMed
    9. Optimizing liver transplant candidacy in patients with cirrhosis and obesity.
      Ha NB, Heimbach JK, Hameed B| | PubMed
    10. Ramadan intermittent fasting for patients with gastrointestinal and hepatobiliary diseases: practical guidance for health-care professionals.
      Usman M, Javed N, Jawhari A, Ghouri N, Waqar S, Shah F, Ahmad S, Hart A, Hameed B, Khan MQ, Peerally MF| | PubMed